Local facts

Novo Nordisk has been operating within the UK for more than 25 years. Diabetes care accounts for 80% of our business in the and we have the broadest diabetes product portfolio in the industry. Haemostasis management represents around 11% of our business and Growth Hormone Therapy and Hormone replacement therapy account for approximately 5% each.

We are committed to improving the lives of patients in diabetes, haemophilia and other serious chronic conditions where we can make a difference.

Headquarters
Headquartered in Crawley, West Sussex, Novo Nordisk in the UK employs around 470 people.  The Irish office in Dublin, ROI employs around 27 employees.

Managing director
The managing director for the UK organisation is Mr Viggo Birch, Vice President Europe - Business Area UK/Ireland

^{UK/WB/0511/009d - Public Site}